Global Gadobutrol Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Gadobutrol Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Gadobutrol (CAS 138071-82-6)
Gadobutrol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gadobutrol market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gadobutrol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Gadobutrol key manufacturers include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), BOC Sciences, LGM Pharma, Advanced Technology & Industrail and MedKoo Biosciences, etc. Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma are top 3 players and held % sales share in total in 2022.
Gadobutrol can be divided into Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) and Pharmacy Bulk Packages (30 mL and 65 mL), etc. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) is the mainstream product in the market, accounting for % sales share globally in 2022.
Gadobutrol is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Gadobutrol industry development. In 2022, global % sales of Gadobutrol went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gadobutrol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Adults
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Gadobutrol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gadobutrol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gadobutrol industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gadobutrol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gadobutrol introduction, etc. Gadobutrol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gadobutrol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Gadobutrol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gadobutrol market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Gadobutrol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Gadobutrol key manufacturers include Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), BOC Sciences, LGM Pharma, Advanced Technology & Industrail and MedKoo Biosciences, etc. Bayer HealthCare Pharmaceuticals, SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma are top 3 players and held % sales share in total in 2022.
Gadobutrol can be divided into Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) and Pharmacy Bulk Packages (30 mL and 65 mL), etc. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) is the mainstream product in the market, accounting for % sales share globally in 2022.
Gadobutrol is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Gadobutrol industry development. In 2022, global % sales of Gadobutrol went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gadobutrol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Bayer HealthCare Pharmaceuticals
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma
Jilin Tely Imp & Exp
JinYan Chemicals (ShangHai)
BOC Sciences
LGM Pharma
Advanced Technology & Industrail
MedKoo Biosciences
Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Segment by Application
Adults
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Gadobutrol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gadobutrol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gadobutrol industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Gadobutrol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gadobutrol introduction, etc. Gadobutrol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gadobutrol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
